These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32023619)

  • 1. Prognostic Significance of Tumor-Infiltrating Lymphocyte Grade in Melanoma: A Meta-Analysis.
    Sun Q; Sun H; Wu N; Cong L; Cong X
    Dermatology; 2020; 236(6):481-492. PubMed ID: 32023619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.
    Weiss SA; Han SW; Lui K; Tchack J; Shapiro R; Berman R; Zhong J; Krogsgaard M; Osman I; Darvishian F
    Hum Pathol; 2016 Nov; 57():116-125. PubMed ID: 27473267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Numerical Scoring System for Melanoma Tumor-infiltrating Lymphocytes Has Better Prognostic Value Than Standard Scoring.
    Saldanha G; Flatman K; Teo KW; Bamford M
    Am J Surg Pathol; 2017 Jul; 41(7):906-914. PubMed ID: 28368925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.
    Thomas NE; Busam KJ; From L; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Groben PA; Hao H; Orlow I; Reiner AS; Luo L; Paine S; Ollila DW; Wilcox H; Begg CB; Berwick M
    J Clin Oncol; 2013 Nov; 31(33):4252-9. PubMed ID: 24127443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of tumor infiltrating lymphocytes in melanoma.
    Burton AL; Roach BA; Mays MP; Chen AF; Ginter BA; Vierling AM; Scoggins CR; Martin RC; Stromberg AJ; Hagendoorn L; McMasters KM
    Am Surg; 2011 Feb; 77(2):188-92. PubMed ID: 21337878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of an automated tumor-infiltrating lymphocyte algorithm for improved prognostication in primary melanoma.
    Chou M; Illa-Bochaca I; Minxi B; Darvishian F; Johannet P; Moran U; Shapiro RL; Berman RS; Osman I; Jour G; Zhong H
    Mod Pathol; 2021 Mar; 34(3):562-571. PubMed ID: 33005020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Tumor-Infiltrating Lymphocytes on Overall Survival in Merkel Cell Carcinoma.
    Butala AA; Jain V; Reddy VK; Sebro RA; Song Y; Karakousis G; Mitchell TC; Lukens JN; Shabason JE
    Oncologist; 2021 Jan; 26(1):63-69. PubMed ID: 32886418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sex.
    Sinnamon AJ; Sharon CE; Song Y; Neuwirth MG; Elder DE; Xu X; Chu EY; Ming ME; Fraker DL; Gimotty PA; Karakousis GC
    J Am Acad Dermatol; 2018 Aug; 79(2):245-251. PubMed ID: 29518458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis.
    Gao G; Wang Z; Qu X; Zhang Z
    BMC Cancer; 2020 Mar; 20(1):179. PubMed ID: 32131780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Melanoma Using Pathologic Features Identified by Natural Language Processing.
    Yang J; Lian JW; Chin YH; Wang L; Lian A; Murphy GF; Zhou L
    JAMA Netw Open; 2021 Sep; 4(9):e2126337. PubMed ID: 34550383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
    J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-infiltrating lymphocyte response in cutaneous melanoma in the elderly predicts clinical outcomes.
    Grotz TE; Vaince F; Hieken TJ
    Melanoma Res; 2013 Apr; 23(2):132-7. PubMed ID: 23344159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor infiltrating lymphocyte grade in Merkel cell carcinoma: relationships with clinical factors and independent prognostic value.
    Yusuf M; Gaskins J; Mandish S; May ME; Wall W; Fisher W; Tennant P; Jorgensen J; Bumpous J; Dunlap N
    Acta Oncol; 2020 Dec; 59(12):1409-1415. PubMed ID: 32687000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
    Gao ZH; Li CX; Liu M; Jiang JY
    BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer.
    Hida AI; Watanabe T; Sagara Y; Kashiwaba M; Sagara Y; Aogi K; Ohi Y; Tanimoto A
    Breast Cancer Res Treat; 2019 Nov; 178(2):283-294. PubMed ID: 31402409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Role of Tumor-Infiltrating Lymphocytes in Esophagus Cancer: a Meta-Analysis.
    Zheng X; Song X; Shao Y; Xu B; Hu W; Zhou Q; Chen L; Zhang D; Wu C; Jiang J
    Cell Physiol Biochem; 2018; 45(2):720-732. PubMed ID: 29414812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer.
    Li J; Wang J; Chen R; Bai Y; Lu X
    Oncotarget; 2017 Feb; 8(9):15621-15631. PubMed ID: 28152503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Retrospective, Observational Analysis of Tumor Infiltrating Lymphocytes and Tumor Regression in Melanoma.
    Zaladonis A; Farma J; Hill M; Hotz M; Meller K; Board T; Deng M; Wu H; Reddy S; O'Halloran E
    J Surg Res; 2021 Nov; 267():203-208. PubMed ID: 34153563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theragnostic significance of tumor-infiltrating lymphocytes and Ki67 in BRAFV600-mutant metastatic melanoma (BRIM-3 trial).
    Googe PB; Theocharis S; Pergaris A; Li H; Yan Y; McKenna EF; Moschos SJ
    Curr Probl Cancer; 2022 Jun; 46(3):100862. PubMed ID: 35398635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local immune response predicts survival in patients with thick (t4) melanomas.
    Cintolo JA; Gimotty P; Blair A; Guerry D; Elder DE; Hammond R; Elenitsas R; Xu X; Fraker D; Schuchter LM; Czerniecki BJ; Karakousis G
    Ann Surg Oncol; 2013 Oct; 20(11):3610-7. PubMed ID: 23838911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.